Volume 15/Issue 4, July 2019
Neonatal abstinence syndrome: a current update
Rohit Kumar, Shalabh Garg
There is an absence of consensus with regard to the monitoring and assessment of neonatal abstinence syndrome (NAS) symptoms and severity, and commencement of pharmacological treatment. As a result different treatment practices have evolved locally, nationally and internationally. The main goals of NAS therapy are to promote infant and maternal regulation and to minimise the signs of NAS expression in the infant by optimising the environment and using pharmacotherapy only when necessary. This article reviews current NAS understanding including antenatal approaches, community-based programmes, follow-up, knowledge gaps and potential future research ideas.
Kumar R., Garg S. Neonatal abstinence syndrome: a current update. Infant 2019;15(4): 132-36.
Abbreviated: Please subscribe and log in to see the full article.